6/6/18
by News Department on 06/06/18Recall...
The US Food and Drug Administration announced the recall of the opioid overdose antidote Naloxone.
The drug has been recalled by its maker, Hospira, due to the potential for “loose particulate matter on the syringe plunger” which could result in a range of adverse events.
No instances have been reported, according to the recall announcement.
Anyone who experiences a related adverse event should report it to the FDA.
Hospira is asking distributors and retailers to discontinue using and distributing the recalled product and notify anyone who they have sent it to including stores, pharmacies, and hospitals.
